IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GENNARELLI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.601
AS - Asia 8.644
EU - Europa 7.686
SA - Sud America 2.016
AF - Africa 183
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 1
Totale 37.182
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.324
CN - Cina 3.246
SG - Singapore 2.718
UA - Ucraina 1.990
BR - Brasile 1.707
PL - Polonia 1.121
HK - Hong Kong 1.093
DE - Germania 1.045
IT - Italia 1.025
VN - Vietnam 564
FI - Finlandia 531
GB - Regno Unito 514
FR - Francia 452
TR - Turchia 359
RU - Federazione Russa 327
IE - Irlanda 325
IN - India 191
AR - Argentina 135
CA - Canada 129
BD - Bangladesh 100
MX - Messico 91
ZA - Sudafrica 72
SE - Svezia 63
ID - Indonesia 61
IQ - Iraq 53
EC - Ecuador 50
NL - Olanda 45
ES - Italia 43
BE - Belgio 42
CZ - Repubblica Ceca 40
AT - Austria 37
JP - Giappone 31
VE - Venezuela 31
MA - Marocco 30
SA - Arabia Saudita 30
PY - Paraguay 27
CO - Colombia 26
PK - Pakistan 26
AU - Australia 24
CL - Cile 22
EU - Europa 21
IR - Iran 21
KE - Kenya 21
UZ - Uzbekistan 20
EG - Egitto 18
LT - Lituania 17
JO - Giordania 16
CH - Svizzera 14
IL - Israele 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 11
TN - Tunisia 11
BG - Bulgaria 9
NP - Nepal 9
PE - Perù 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
HN - Honduras 8
KR - Corea 8
KZ - Kazakistan 8
MU - Mauritius 8
PA - Panama 8
AL - Albania 7
DZ - Algeria 7
KG - Kirghizistan 7
OM - Oman 7
UY - Uruguay 7
HU - Ungheria 6
RO - Romania 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BH - Bahrain 5
CR - Costa Rica 5
ET - Etiopia 5
PH - Filippine 5
BY - Bielorussia 4
GE - Georgia 4
LU - Lussemburgo 4
NO - Norvegia 4
PT - Portogallo 4
SV - El Salvador 4
AO - Angola 3
BB - Barbados 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GA - Gabon 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
BA - Bosnia-Erzegovina 1
Totale 37.166
Salva come PNG Salva come JPEG
Città #
Fairfield 2.491
Woodbridge 1.991
Ashburn 1.445
Jacksonville 1.430
Singapore 1.331
Houston 1.283
Warsaw 1.116
Hong Kong 1.088
Ann Arbor 1.076
Cambridge 1.007
Seattle 939
Wilmington 831
Chandler 654
Beijing 602
Princeton 602
Nanjing 517
New York 358
Dublin 320
Los Angeles 303
Brescia 301
Istanbul 290
Dearborn 230
Helsinki 219
Ho Chi Minh City 213
Nanchang 212
Des Moines 204
Munich 171
Shenyang 156
Buffalo 152
São Paulo 148
Changsha 141
Hebei 139
The Dalles 137
San Diego 132
Moscow 125
Milan 117
Redondo Beach 115
Shanghai 115
Lancaster 106
Jinan 104
San Francisco 102
Hanoi 94
Chicago 93
Tianjin 91
Jiaxing 85
Dallas 76
London 69
Dong Ket 68
Kunming 64
Verona 63
Turku 61
Hangzhou 58
Norwalk 57
Boardman 55
Zhengzhou 52
Guangzhou 50
Lanzhou 50
Rio de Janeiro 49
Santa Clara 49
Ningbo 47
Belo Horizonte 45
Nuremberg 44
Toronto 44
Brooklyn 42
Brussels 41
Johannesburg 40
Haikou 39
Mexico City 39
Montreal 34
Romola 34
San Mateo 34
Bolzano 32
Rome 30
Brasília 28
Jakarta 28
Leawood 27
Stockholm 27
Tokyo 27
Brno 26
Denver 26
Phoenix 25
Porto Alegre 25
Kocaeli 24
Atlanta 23
Campinas 23
Salvador 23
Augusta 22
Haiphong 22
Washington 22
Fuzhou 21
Curitiba 20
Frankfurt am Main 20
Hefei 20
Nairobi 20
Orem 20
Charlotte 19
Dhaka 19
Fortaleza 19
Salt Lake City 19
Boston 18
Totale 25.355
Salva come PNG Salva come JPEG
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 309
New Copy Number Variations in Schizophrenia 302
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 298
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 269
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 252
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 230
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 224
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 212
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 203
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 201
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation 200
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients 200
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 198
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 195
New biological pathways for major depression: gene expression decomposition in G x E components 191
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. 191
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 190
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 184
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 180
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 180
The role of the potassium channel gene KCNK2 in major depressive disorder 175
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. 173
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 172
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 171
Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. 171
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 169
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 169
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 168
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 166
A genome-wide investigation of SNPs and CNVs in schizophrenia. 161
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 161
A putative regulatory subunit (NR3A) of the NMDA receptor complex as candidate gene for susceptibility to schizophrenia: a case-control study. 159
The role of GRIK4 gene in treatment-resistant depression 159
Glucose metabolism alterations in patients with bipolar disorder 158
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. 155
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association study. 155
BDNF Val66Met polymorphism and protein levels in amniotic fluid. 155
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 154
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 154
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline 'Predictors' and Longitudinal 'Targets' 153
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. 152
Analysis of Copy Number Variations in Schizophrenia Italian Patients 151
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 151
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 151
Next Generation Sequencing Analysis in Early Onset Dementia Patients 151
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 149
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 148
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine. 147
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. 147
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 147
Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. 146
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 146
MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder 145
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 144
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 144
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study 143
Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. 142
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia 142
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 141
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. 139
The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment 139
ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder. 139
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 138
Diagnostic accuracy of markers for prodromal Alzheimer's disease in independent clinical series 138
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. 138
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 137
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels 136
Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus 135
PCLO gene: Its role in vulnerability to major depressive disorder. 135
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial. 135
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 135
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment. 135
Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms. 134
Heterozygous TREM2 mutations in frontotemporal dementia 134
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. 132
Immune and metabolic alterations in first episode psychosis (FEP) patients 132
Serum sortilin-derived propeptides concentrations are decreased in major depressive disorder patients 132
The influence of psychiatric screening in healthy populations selection: a new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. 131
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 130
TWO PEDIGREES OF AUTOSOMAL DOMINANT ATRIOVENTRICULAR CANAL DEFECT (AVCD): EXCLUSION FROM THE CRITICAL REGION ON 8p. 130
Seizure Adequacy Markers and the Prediction of Electroconvulsive Therapy Response 130
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 130
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 130
VEGF Haplotypes are Associated with Increased Risk to Progressive Supranuclear Palsy and Corticobasal Syndrome. 129
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence. 129
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). 129
GENOTYPING OF SPINAL MUSCULAR ATROPHY FAMILIES WITH LINKED DNA PROBES. 128
STUDY OF THE EFFECTS ON DNA OF ELECTROMAGNETIC FIELDS USING CLAMPED HOMOGENEOUS ELECTRIC FIELD GEL ELECTROPHORESIS. 128
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. 128
INFLAMMATORY AND NEUROTROPHIC FACTORS UNBALANCE IN LEUKOCYTES OF FIRST EPISODE PSYCHOSIS PATIENTS 128
Genetic variations and association. 128
Blood microRNA changes in depressed patients during antidepressant treatment. 128
Influence of GRIK4 genetic variants on the electroconvulsive therapy response 128
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 128
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 128
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 127
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 127
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 126
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 125
NATURAL HISTORY OF CARDIAC INVOLVEMENT IN MYOTONIC DYSTROPHY: CORRELATION WITH CTG REPEATS. 125
Totale 15.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 185.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.083 0 0 0 0 0 500 213 513 683 414 550 210
2021/20222.396 158 541 56 56 14 98 206 142 172 238 206 509
2022/20232.084 349 12 31 146 190 620 6 208 315 32 94 81
2023/20242.135 127 52 188 131 95 349 60 72 588 37 37 399
2024/20255.439 47 55 82 615 592 516 392 189 513 585 1.034 819
2025/20266.539 1.042 1.622 852 1.769 1.142 112 0 0 0 0 0 0
Totale 37.708